Product Name | Catalog # | Price | Qty | |
---|---|---|---|---|
Human HIF-Regulated cDNA Profiling in Cell Lysates | AP-3102 | $635 |
Characterization
Description(s):Rapidly growing tumors result in hypoxic regions. Adaptive responses of most cells to hypoxia are (1) to produce VEGF and other hypoxia-induced angiogenic cytokines that promote increased tissue vascularization, thereby increasing tissue oxygenation, and (2) to switch metabolically from oxidative phosphorylation to anaerobic glycolysis. Hypoxia-inducible factor 1 (HIF-1) is an oxygen-regulated transcriptional activator that plays essential roles in the process. The HIF-1alpha subunit is oxygen-dependent ubiquitination and proteasomal degradation. In addition, cytokines including interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-alpha) stimulate HIF-1 dependent gene expression. HIF-1 increases the expression of several genes that promote blood flow and inflammation, such as vascular endothelial growth factor (VEGF). To get a better overview of gene expression of HIF-1 regulated genes, Signosis has developed a cDNA Plate Array which couples its CLTM cDNA synthesis kit which allows reverse transcription directly from cell lysates without RNA preparation. This plate-based assays allows profiling the expression of 20+ HIF-1-regulated genes directly in cell lysates. This assay provides quantitative data, allowing researchers to screen multiple samples, as well as high sensitivity, allowing researchers to use less sample.
Applicable Grid:
List of Applicable Genes
BCL2 | HIF-2a | PDGF-A | BCL2 | HIF-2a | PDGF-A | BCL2 | HIF-2a | PDGF-A | BCL2 | HIF-2a | PDGF-A |
Beta-actin | HPRT | PDK1 | Beta-actin | HPRT | PDK1 | Beta-actin | HPRT | PDK1 | Beta-actin | HPRT | PDK1 |
CA9 | IGF-II | NDRG1 | CA9 | IGF-II | NDRG1 | CA9 | IGF-II | NDRG1 | CA9 | IGF-II | NDRG1 |
CTSD | Leptin | SAG | CTSD | Leptin | SAG | CTSD | Leptin | SAG | CTSD | Leptin | SAG |
BHLHB2 | MMP1 | SLC6A8 | BHLHB2 | MMP1 | SLC6A8 | BHLHB2 | MMP1 | SLC6A8 | BHLHB2 | MMP1 | SLC6A8 |
Glut-1 | MXI-1 | VEGF | Glut-1 | MXI-1 | VEGF | Glut-1 | MXI-1 | VEGF | Glut-1 | MXI-1 | VEGF |
Glut-3 | NDRG2 | VHL | Glut-3 | NDRG2 | VHL | Glut-3 | NDRG2 | VHL | Glut-3 | NDRG2 | VHL |
HIF-1a | PAI-1 | Blank | HIF-1a | PAI-1 | Blank | HIF-1a | PAI-1 | Blank | HIF-1a | PAI-1 | Blank |
Principle
Unlike conventional reverse transcription which needs total RNA, Signosis has developed a CL(TM) cDNA synthesis-based plate array. It can synthesize cDNA probes through reverse transcription directly in cell lysates without RNA preparation. The synthesized cDNA probes are then applied for a plate array hybridization. Targeted genes are specifically captured onto individual wells on a plate through a pre-coated gene-specific oligonucleotide. The captured cDNAs are further detected with streptavidin-HRP. Luminescence is reported as relative light units (RLUs) on a microplate luminometer. The expression level of genes is directly proportional to the luminescent intensity.